Evidence map›Paper›PMID 40612302›Full record

ReviewFrontiers in nutrition2025

Adapting the Crohn's disease exclusion diet to a Nordic framework: a theoretical approach to cultural and nutritional customization.

N Vivanco Karlsson, R Sigall-Boneh, K Mårild, E M Hård Af Segerstad

Registry-linked trialAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07334340 (Modified vs Standard Crohn´s Disease Exclusion Diet), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07334340 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Modified vs Standard Crohn´s Disease Exclusion Diet: Evaluation of a Nordic Adaptation of Nutritional Therapy in Paediatric Crohn's Diseas

TypeinterventionalSponsorVastra Gotaland RegionRan2026 to 2030Enrolled30ConditionsPediatric Crohns DiseaseArmsNordic Crohn´s Disease Exclusion Diet
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

N Vivanco KarlssonDepartment of Pediatrics, Skaraborg Hospital, Skövde, Sweden.
R Sigall-BonehPediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon, Israel.
K MårildDepartment of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden.
E M Hård Af SegerstadPediatric Research Institute, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging evidence from diverse populations highlights the therapeutic benefits of the Crohn's Disease Exclusion Diet (CDED) in managing Crohn's Disease. To improve the efficacy of the CDED, there is a need to focus on cultural adaptation and individualization to support dietary adherence to this advanced nutritional therapy. This paper provides a theoretical framework for modifying the CDED to align with a Nordic diet (Nordic-CDED), while retaining the core principles and nutritional characteristics of the original protocol. Through a comprehensive literature review and expert consensus, we propose a Nordic-CDED that incorporates European regulations on food additives, the 2023 Nordic Nutritional Recommendations, and Nordic food culture. We present a theoretical foundation for an inclusion of whole foods and discuss the selection of enteral formulas. The adaptation also emphasizes the importance of dietitian-led guidance to tailor the Nordic-CDED to the patient's age, lifestyle, and personal preferences. Further research is required to assess the clinical effectiveness and adherence to the Nordic-CDED.

Indexed as

Crohn’s disease exclusion dietenteral nutritionNordic dietnutritional treatmentpediatric Crohn’s disease

Identifiers

PMID40612302
PMCPMC12224439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.